Data
Click on Protocol Number of interest to view study-related documentation or download data files.
(DTMC data files are under development.)
| Division | Study Number Sort ascending | Title | Investigator(s) | Release Date |
|---|---|---|---|---|
| DTMC | NIDA-CTO-0005 | Double-Blind, Placebo-Controlled Trial Of Ondansetron For The Treatment Of Cocaine Dependence | John D. Roache, Ph.D. | Aug 01, 2016 |
| DTMC | NIDA-CTO-0004 | Assessment Of Potential Interactions Between Intravenous Methamphetamine And Oral Selegiline | Thomas F. Newton, M.D. | Aug 01, 2016 |
| DTMC | NIDA-CTO-0003 | Assessment Of Potential Interactions Between Intravenous Cocaine And Tolcapone | Thomas F. Newton, M.D. | Aug 01, 2016 |
| DTMC | NIDA-CTO-0002 | Safety Evaluation Of Cocaine Treatment Medication, Modafinil: Interactions With Intravenous Cocaine | Robert J. Malcolm, M.D., C. Lindsay DeVane, Pharm.D. | Aug 01, 2016 |
| DTMC | NIDA-CTO-0001 | Phase 2, Double-Blind, Placebo-Controlled Trial Of Reserpine For The Treatment Of Cocaine Dependence | Eugene Somoza, M.D. | Dec 04, 2014 |
| CTN | NIDA-CTN-AWARE | Project Aware: HIV Rapid Testing & Counseling in STD Clinics in the U.S. – an Adaptation of CTN-0032 | Lisa Metsch, Ph.D., Grant Colfax, M.D. | Jul 03, 2014 |
| CTN | NIDA-CTN-0093 | Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool | Gerald Cochran, PhD, T. John Winhusen, Ph.D. | Apr 13, 2023 |
| CTN | NIDA-CTN-0075 | Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder | Li-Tzy Wu, Psy.D., Paolo Mannelli, MD | Feb 16, 2023 |
| CTN | NIDA-CTN-0068 | Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT-2) | Madhukar H. Trivedi, M.D. | Oct 07, 2022 |
| CTN | NIDA-CTN-0067 | Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up | P. Todd Korthuis, MD | Jul 26, 2023 |